Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.
Sponsor: OHSU Knight Cancer Institute
You may qualify if…
- ✓ INTERVENTION PARTICIPANTS: Age 18 or older
- ✓ INTERVENTION PARTICIPANTS: Diagnosed with histologically confirmed prostate cancer
- ✓ INTERVENTION PARTICIPANTS: Received \>= 6 months of ADT any time in the past 10 years
- ✓ INTERVENTION PARTICIPANTS: Completed radiotherapy, chemotherapy and/or surgery \> 6 weeks prior to
- ✓ INTERVENTION PARTICIPANTS: No intent to start adjuvant chemotherapy or radiotherapy within 6 months of enrollment
- ✓ INTERVENTION PARTICIPANTS: Overweight or obese (body mass index \> 25 kg/m2 to BMI ≤ 50).
- ✓ INTERVENTION PARTICIPANTS: Evidence of frailty by meeting three or more of the following frailty criteria: weakness, slowness, fatigue, inactivity, and/or illness
- ✓ INTERVENTION PARTICIPANTS: Not currently engaging in structured diet or resistance strength training exercise program
You may not qualify if…
- ✕ INTERVENTION PARTICIPANTS: Unintentional weight loss \> 5% within the last year
- ✕ INTERVENTION PARTICIPANTS: Contraindication to moderate intensity exercise
- ✕ INTERVENTION PARTICIPANTS: Health or medical condition that affects weight status/body composition (e.g., Cushing's syndrome, uncontrolled hyper-/hypo- thyroidism)
- ✕ INTERVENTION PARTICIPANTS: Active malignancy (other than non-melanoma skin cancer)
- ✕ INTERVENTION PARTICIPANTS: Not fluent in English and therefore incapable of answer survey questions, following directions during exercise or performance testing, and providing informed consent in English
- ✕ INTERVENTION PARTICIPANTS: Currently taking or have taken creatine supplement in the month preceding baseline creatine testing
Where it's recruiting
Portland
Source: ClinicalTrials.gov · NCT06011499 · last updated 2026-05-08